Otero Jose Manuel — SEC Form 4 filings
SEC reporting owner CIK 2024096. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-06-14 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 16,693 shares, $98,842 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 4,666 shares @ $4.48 ($20,904) in Lexeo Therapeutics, Inc., filed 2026-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | 13 | — | 9 legs · 16,693 sh · $98,842 | 10 |
Form 4 filings — Otero Jose Manuel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 1,304 @ $4.96 | EDGAR |
| 2026-07-01 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 12,060 @ $0 · Sale (S): 4,666 @ $4.48 | EDGAR |
| 2026-05-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 1,302 @ $5.07 | EDGAR |
| 2026-03-17 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 5,930 @ $2.64 | EDGAR |
| 2026-02-20 | 4/A | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 721 @ $9.27 | EDGAR |
| 2026-02-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 3,016 @ $6.40 | EDGAR |
| 2026-02-06 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 721 @ $9.27 | EDGAR |
| 2025-10-17 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 5,940 @ $0 · Sale (S): 2,091 @ $8.94 · Sale (S): 24 @ $9.56 | EDGAR |
| 2025-08-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 2,848 @ $4.67 | EDGAR |
| 2025-04-09 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 5,720 @ $2.61 | EDGAR |
| 2025-01-10 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 26,250 @ $0 · Grant/award (A): 52,500 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 31,250 @ $0 · Grant/award (A): 187,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2024096 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →